Pharmaceutical developer Enochian Biosciences Inc. said it is taking legal action against its co-founder and former scientific adviser, alleging he altered data in drug studies on COVID-19 and hepatitis B.
Inc. said it is taking legal action against its co-founder and former scientific adviser, alleging he altered data in two different drug studies.
The company said Friday that an internal review found that Serhat Gumrukcu, falsified two different sets of animal data generated by third-party research institutions. One data set was used for a study of inhaled Covid-19 treatment, and the other was used for a hepatitis B virus therapy study. Mr. Gumrukcu’s attorneys couldn’t immediately be reached for comment.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Experts Say We Should All Be Storing Our Poo in a Bank, And Here's WhyFecal transplants continue to make headlines in recent years, showing promise in everything from COVID-19 treatments to anti-aging experiments in animals, but we're still only scratching the surface, scientists say.
Read more »
FDA panel says new boosters should protect against Omicron subvariants BA.4 and BA.5Earlier this week, that panel voted to recommend including some type of omicron-specific protection in the next set of COVID-19 boosters.
Read more »
Highly contagious strains dominate other COVID-19 variants in North TexasTwo highly contagious and closely related COVID-19 variants now are the dominant strains being found by UT Southwestern Medical Center as cases and...
Read more »
Scripps Health urges COVID caution over Fourth of July weekendAt Scripps alone, the number of hospitalized COVID-19 patients increased to 96 on Wednesday — more than double the 45 COVID patients at its hospitals a month ago.
Read more »
Tiger at Columbus Zoo dies of complications from COVID-19The 14-year-old Amur tiger, named Jupiter, died on Sunday. Jupiter is the first animal at the zoo to die from complications from COVID-19.
Read more »